HR 4084
115th Congress
House
Crime and Law Enforcement
Drug trafficking and controlled substances
Licensing and registrations
Prescription drugs
Retail and wholesale trades
To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
Introduced: October 19, 2017
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Oct 20, 2017
Referred to the Subcommittee on Health.
Oct 19, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 19, 2017
Introduced in House
Plain-English summary
This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Committees of jurisdiction
4